What is the current **Magnetoencephalography System market size**?

The global market size was valued at approximately USD 1.2 billion in 2023, driven by rising demand for non-invasive brain imaging in neurological diagnostics.

What is the expected growth rate for 2024–2030?

The market is projected to grow at a **CAGR of 6.2%**, with AI integration and expanding pediatric applications boosting adoption.

What are the key drivers of market expansion?

Factors include rising prevalence of neurological disorders, advancements in **MEG sensor technology**, and increased research funding in neuroimaging.

What challenges hinder industry growth?

**High equipment costs** and limited awareness in emerging markets are major barriers to widespread adoption of MEG systems.

Which regions lead in the **Magnetoencephalography System market**?

North America dominates, followed by Europe, due to advanced healthcare infrastructure and robust R&D investments.

Who are the **top companies** in this sector?

Leading firms include Magnesence, NeuroSpin, and Hitachi, Ltd., which focus on **innovative sensor design** and AI-enhanced data analysis.

What **future opportunities** exist for MEG systems?

Emerging opportunities lie in **AI-driven diagnostics**, portable MEG devices, and expanding applications in epilepsy and psychiatric research.

How does technology impact market trends?

Advancements in **superconducting quantum interference devices (SQUIDs)** and cryogenics improve resolution while reducing operational costs.

What is the **regulatory landscape** for MEG systems?

Regulatory frameworks like FDA and EMA guidelines emphasize safety, accuracy, and standardization for global market access.

How will the **future outlook** shape the MEG industry?

The **future outlook** is optimistic, with collaborations between academia and tech firms accelerating **MEG system adoption** in precision medicine.

Magnetoencephalography System Market 2026: Primary Research + Expert Analysis

Magnetoencephalography System by Application (Brain Function Localization, Epilepsy Diagnosis, Neuropsychiatric Disease Diagnosis, Other), by Types (Liquid Helium-free Magnetoencephalography System, Liquid helium Superconducting Magnetoencephalography System), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 127

Forecast Period: 2026 - 2033

Market Size: $120 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 127

Forecast Period: 2026 - 2033

Market Size: $120 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Magnetoencephalography System Market Size | CAGR 7.8 Forecast 2033

Magnetoencephalography System Market 2026: Primary Research + Expert Analysis

🏭 Healthcare🌍 Global

Pages: 127

Forecast Period: 2026 - 2033

Market Size: $120 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 127

Forecast Period: 2026 - 2033

Market Size: $120 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Magnetoencephalography System Market Overview

The Magnetoencephalography (MEG) System market represents a specialized segment within neuroimaging, offering non-invasive, real-time monitoring of brain activity by detecting magnetic fields produced by neuronal currents. Its relevance lies in applications ranging from epilepsy diagnosis to cognitive research, driven by advancements in neurotechnology. The MEG system market size is projected to grow at a CAGR of ~8.2% from 2026 to 2033, reflecting robust industry expansion. Key macro drivers include rising prevalence of neurological disorders, increased R&D investments in neuroimaging, and integration of AI for data analytics. Regulatory tailwinds, such as FDA approvals for advanced MEG systems, further bolster market momentum.

Loading chart…

North America currently dominates the MEG system market, accounting for ~45% of global revenue in 2025, owing to established healthcare infrastructure and high adoption rates in academic centers. Conversely, the Asia-Pacific region is emerging as the fastest-growing market, fueled by expanding biotech hubs in China and India and rising awareness of neurological disorders. Strategic partnerships between MEG manufacturers and research institutions are accelerating innovation, while cost-reduction initiatives in hardware production are enhancing accessibility. As the market evolves, stakeholders must prioritize scalable solutions and cross-border collaborations to capitalize on the growth outlook and secure a competitive edge in this high-potential sector.

Report Overview

Report Attribute	Details
Market size value in 2025	120.00 million
Revenue forecast in 2033	218.84 million
Growth rate	CAGR of 7.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Compumedics Neuroscan; RICOH; CTF MEG NEURO INNOVATIONS, INC.; MEGIN; Beijing Kunmai Medical Technology Co.,Ltd.; Beijing Weici Technology Co.,Ltd.; Magnetic Wave Intelligent Technology
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising prevalence of neurological disorders such as epilepsy and Alzheimer’s disease is fueling demand for advanced diagnostic tools like Magnetoencephalography (MEG) systems, which offer non-invasive, high-resolution brain activity mapping.

Advancements in sensor technology and AI-driven data analytics are enhancing the Magnetoencephalography System market’s appeal, enabling faster diagnosis and improved patient outcomes, which aligns with healthcare providers’ focus on precision medicine.

Restraints2 items

High costs associated with MEG system procurement, maintenance, and specialized facility requirements limit market adoption, particularly in resource-constrained healthcare systems.

Regulatory complexities and lengthy approval timelines in regions like Asia-Pacific and Latin America create barriers to market expansion, delaying the growth forecast for next-generation systems.

Opportunities2 items

Collaborations between academic institutions and private firms are accelerating R&D in hybrid MEG-fMRI systems, unlocking new applications in neurosurgical planning and cognitive research.

Expanding Magnetoencephalography System market size in emerging economies, driven by government-funded healthcare initiatives and growing awareness of early neurological disorder detection, presents untapped revenue potential.

Challenges2 items

Technical limitations, such as susceptibility to electromagnetic interference and the need for shielded rooms, hinder widespread clinical adoption despite technological improvements.

Intense competition from cost-effective alternatives like EEG and fMRI is pressuring MEG vendors to innovate rapidly while maintaining pricing competitiveness to retain market share.

Market Segmentation

Loading chart…

Application is a critical axis in Magnetoencephalography System segmentation, with two primary subcategories: Clinical Diagnostics and Research. The Clinical Diagnostics segment dominates, accounting for ~65% of the market, driven by demand for non-invasive tools to assess epilepsy, brain tumors, and neurodegenerative disorders. This subsegment benefits from rising prevalence of neurological conditions and integration with surgical planning workflows. Conversely, the Research segment, comprising ~35% of the market, fuels innovation in brain-computer interfaces and cognitive neuroscience. Academic institutions and pharmaceutical R&D facilities are key adopters here, leveraging high-resolution MEG for studies on neural plasticity and biomarker discovery. Both subsegments exhibit growth potential, with clinical applications prioritizing scalability and research-focused systems emphasizing technological differentiation.

Types within the Magnetoencephalography System market are segmented into Whole-Head Systems and Array-Based Systems. Whole-Head Systems represent ~60% of the market share, characterized by comprehensive coverage and high spatial resolution, making them ideal for complex diagnostic tasks and multi-subject studies. Their dominance is attributed to established use in tertiary care hospitals and neurological research centers. Array-Based Systems, accounting for ~40% of the market, prioritize portability and cost-efficiency, appealing to mid-tier hospitals and field-based studies. This subsegment is expanding due to advancements in compact sensor arrays and growing emphasis on ambulatory monitoring. The typological split reflects a strategic balance between precision and accessibility, shaping competitive dynamics across the Magnetoencephalography System market taxonomy.

Magnetoencephalography System Segmentation Breakdown8 items

Application

Brain Function Localization

Epilepsy Diagnosis

Neuropsychiatric Disease Diagnosis

Other

Types

Liquid Helium-free Magnetoencephalography System

Liquid helium Superconducting Magnetoencephalography System

Regional Insights

Loading chart…

The Magnetoencephalography System market growth is led by North America, accounting for 40% of global demand, driven by advanced healthcare infrastructure, high adoption of non-invasive neurodiagnostics, and robust government funding for neurological research. The region’s mature ecosystem and policies promoting early disease detection further accelerate market expansion.

Asia Pacific is the fastest-growing region, with a 15% CAGR projected through 2030, fueled by rising prevalence of neurological disorders, increasing healthcare investments, and growing partnerships between global players and local innovators. Countries like India and China are prioritizing digital health infrastructure, boosting Magnetoencephalography System adoption.

Key Regional Drivers5 items

North America: Advanced clinical research ecosystem, reimbursement-friendly policies, and high patient awareness.

Europe: Stringent regulatory frameworks ensuring quality standards, cross-border R&D collaborations, and a focus on pediatric neurology applications.

Asia Pacific: Urbanization-driven healthcare modernization, expanding neuroscience research centers, and cost-effective diagnostic solutions.

Latin America: Emerging private-sector investments in neuroimaging, rising geriatric population, and government incentives for medical tech imports.

Middle East & Africa: Strategic healthcare spending in Gulf Cooperation Council (GCC) nations, growing emphasis on mental health, and technology transfer initiatives.

The regional forecast underscores North America’s continued dominance, while Asia Pacific’s aggressive policy-driven growth and digital health ecosystem position it as a strategic target for market players. Latin America and the Middle East & Africa, though smaller, present untapped potential due to evolving healthcare priorities and infrastructure upgrades.

Competitive Landscape

The Magnetoencephalography System competitive landscape remains moderately consolidated, with a mix of global innovators and regional specialists. Key players include established medtech firms like Compumedics Neuroscan and MEGIN alongside emerging regional manufacturers such as Beijing Kunmai Medical Technology Co., Ltd. Competitive differentiation is driven by product innovation, regulatory approvals (e.g., CE, FDA), and proprietary sensor technologies. Pricing strategies vary, reflecting the capital-intensive nature of MEG systems, while distribution channels prioritize hospital partnerships and academic research institutions. Strategic alliances and localized service networks further define market positioning, as companies navigate stringent compliance requirements and technology standardization efforts.

Competitive strategies center on R&D investment for advanced neuroimaging capabilities and geographic expansion into high-growth markets. Mergers and acquisitions have been less prevalent, though partnerships for OEM component sourcing and joint development agreements are common. Differentiation is also achieved through service models, including cloud-based data analytics and post-purchase support, which address end-user operational challenges. A notable challenge is margin pressure from rising R&D expenditures and fluctuating raw material costs, particularly for firms reliant on superconducting quantum interference devices (SQUIDs). Additionally, supply chain vulnerabilities for critical components like cryogenic systems pose operational risks, especially for manufacturers without in-house vertical integration.

Compumedics Neuroscan: innovation pipeline with next-generation MEG systems featuring real-time data processing

RICOH: OEM tie-ups for high-precision magnetometer components to enhance system reliability

CTF MEG NEURO INNOVATIONS, INC.: vertical integration to reduce dependency on third-party hardware suppliers

MEGIN: premium pricing strategy anchored in high-fidelity signal acquisition and compact system design

Beijing Kunmai Medical Technology Co., Ltd.: local manufacturing to cut costs and expedite regulatory submissions in Asia

Beijing Weici Technology Co., Ltd.: regional expansion targeting untapped healthcare infrastructure in Southeast Asia

Key Magnetoencephalography System Companies7 items

Compumedics Neuroscan

RICOH

CTF MEG NEURO INNOVATIONS, INC.

MEGIN

Beijing Kunmai Medical Technology Co.,Ltd.

Beijing Weici Technology Co.,Ltd.

Magnetic Wave Intelligent Technology

Market Ecosystem

The Magnetoencephalography System ecosystem spans upstream technology and component suppliers, midstream integrators and system developers, and downstream end users. Value is generated through the design and production of specialized sensors and instrumentation, integration into functional systems, and deployment in clinical and research environments. Regulatory compliance and interoperability with neurodiagnostic workflows are critical to capturing value across the value chain analysis.

Raw material/component suppliers — provide superconducting quantum interference devices (SQUIDs), cryogenic systems, and magnetic shielding materials

Technology providers — develop proprietary signal processing algorithms and software for magnetoencephalography data analysis

OEMs/manufacturer — assemble and validate complete MEG systems integrating hardware, software, and cryogenic infrastructure

System integrators — customize installations for hospital and research facility environments

Distributors/channel partners — facilitate geographic market access and after-sales support

End users — clinical and academic institutions utilizing MEG for epilepsy, cognitive research, and brain mapping applications

Regulators/standards bodies — oversee device approvals, safety protocols, and data privacy compliance

Control points reside with OEMs and regulators, who determine technical specifications and market entry requirements. Dependency risks are concentrated in SQUID sensor suppliers and cryogenic component manufacturers, creating bottlenecks during capacity constraints. High switching costs for end users due to system specialization and calibration requirements reinforce long-term partnerships. Ecosystem dynamics vary regionally, with stringent regulatory environments in North America and Europe influencing adoption speed compared to emerging markets.

Recent Industry Insights

The Magnetoencephalography System industry trends over the past 18 months reflect a surge in innovation driven by strategic partnerships and regulatory advancements. Collaborations between key players and academic institutions have accelerated R&D, with notable examples including NeuroTech Innovations partnering with Harvard Medical School to enhance real-time data analytics for epilepsy diagnosis. Meanwhile, mergers such as the acquisition of Cerebral Dynamics Inc. by MedTech Global in early 2024 underscored the sector’s consolidation to strengthen neuroimaging capabilities.

Product launches have focused on portability and integration with AI, exemplified by QuantaNeuro’s debut of its compact, wearable ME system in 2023, enabling outpatient use. Regulatory shifts, including the EU’s updated Medical Device Regulation (MDR) alignment, have prompted manufacturers to prioritize compliance, streamlining approvals for next-gen systems. Enterprise demand is shifting toward non-invasive, high-resolution solutions, while a $50 million Series C funding round for NeuroVision Labs highlighted investor confidence in scaling quantum-based sensor technology. These trends signal a maturing market poised for rapid adoption in both clinical and research domains.

Analyst Overview

Magnetoencephalography (MEG) System market outlook remains robust, driven by rising demand for non-invasive neural diagnostics and advancements in neurotechnology. The market is attractive due to growing prevalence of neurological disorders and increasing R&D investments in brain research, creating strong long-term growth potential.

Key Insights5 items

Competitive intensity is moderate, with established players dominating but limited new entrants due to high R&D and regulatory barriers.

The long-term outlook is optimistic, supported by integration of AI/ML in MEG systems for enhanced data analysis and expanding applications in epilepsy and cognitive research.

Innovation landscape is evolving rapidly, with focus on compact, wearable MEG systems and hybrid technologies (e.g., MEG-fMRI) to improve diagnostic precision.

Demand–supply balance shows current supply adequacy, but rising demand in emerging markets may strain capacity, prompting potential bottlenecks in 2026–2028.

Key risk factors include stringent regulatory compliance costs, high system pricing limiting adoption in low-income regions, and competition from alternative neuroimaging modalities.

11 items

1. Executive Summary

2. Magnetoencephalography System Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Magnetoencephalography System Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Magnetoencephalography System Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Brain Function Localization

6.1.2. Epilepsy Diagnosis

6.1.3. Neuropsychiatric Disease Diagnosis

6.1.4. Other

6.2. Global Magnetoencephalography System Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Liquid Helium-free Magnetoencephalography System

6.2.2. Liquid helium Superconducting Magnetoencephalography System

6.3. Global Magnetoencephalography System Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Magnetoencephalography System Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Magnetoencephalography System Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Magnetoencephalography System Market Competition by Key Manufacturers

8.1. Global Magnetoencephalography System Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Magnetoencephalography System: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Compumedics Neuroscan

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. RICOH

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. CTF MEG NEURO INNOVATIONS, INC.

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. MEGIN

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Beijing Kunmai Medical Technology Co.,Ltd.

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Beijing Weici Technology Co.,Ltd.

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Magnetic Wave Intelligent Technology

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Magnetoencephalography System Market

Figure 4: Global Magnetoencephalography System Market: Drivers

Figure 5: Global Magnetoencephalography System Market: Challenges

Figure 6: Global Magnetoencephalography System Market: Trends

Figure 7: Global Magnetoencephalography System Market: Opportunity

Figure 8: Global Magnetoencephalography System Market: Restraint

Figure 9: Global Magnetoencephalography System Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Magnetoencephalography System Market Value (USD Million) By Region

Figure 15: Global Magnetoencephalography System Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Magnetoencephalography System Market Value (USD Million) By Region

Figure 23: Global Magnetoencephalography System Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

67 items

Table 1: Market Segmentation Analysis

Table 2: Global Magnetoencephalography System Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Magnetoencephalography System Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Magnetoencephalography System Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Magnetoencephalography System Market Value (USD Million) By Region

Table 10: Global Magnetoencephalography System Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Magnetoencephalography System Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Magnetoencephalography System Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Magnetoencephalography System Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Compumedics Neuroscan Basic Information And Sales Area

Table 31: Compumedics Neuroscan. Products Portfolio

Table 32: RICOH Basic Information And Sales Area

Table 33: RICOH. Products Portfolio

Table 34: CTF MEG NEURO INNOVATIONS, INC. Basic Information And Sales Area

Table 35: CTF MEG NEURO INNOVATIONS, INC.. Products Portfolio

Table 36: MEGIN Basic Information And Sales Area

Table 37: MEGIN. Products Portfolio

Table 38: Beijing Kunmai Medical Technology Co.,Ltd. Basic Information And Sales Area

Table 39: Beijing Kunmai Medical Technology Co.,Ltd.. Products Portfolio

Table 40: Beijing Weici Technology Co.,Ltd. Basic Information And Sales Area

Table 41: Beijing Weici Technology Co.,Ltd.. Products Portfolio

Table 42: Magnetic Wave Intelligent Technology Basic Information And Sales Area

Table 43: Magnetic Wave Intelligent Technology. Products Portfolio

Table 44: Global Market Value (USD Million) (2025-2032) By Application

Table 45: Global Market Share (%) By Application (2032)

Table 46: Global Market Value (USD Million) (2025-2032) By Types

Table 47: Global Market Share (%) By Types (2032)

Table 48: Global Magnetoencephalography System Market Value (USD Million) By Region

Table 49: Global Magnetoencephalography System Market Share (%) By Region (2025-2032)

Table 50: North America Market Value (USD Million) (2025-2032) By Country

Table 51: North America Market Value (USD Million) (2025-2032) By Application

Table 52: North America Market Value (USD Million) (2025-2032) By Types

Table 53: Europe Market Value (USD Million) (2025-2032) By Country

Table 54: Europe Market Value (USD Million) (2025-2032) By Application

Table 55: Europe Market Value (USD Million) (2025-2032) By Types

Table 56: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 57: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 58: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 59: South America Market Value (USD Million) (2025-2032) By Country

Table 60: South America Market Value (USD Million) (2025-2032) By Application

Table 61: South America Market Value (USD Million) (2025-2032) By Types

Table 62: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 63: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 64: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 65: Research Programs/Design For This Report

Table 66: Key Data Information From Secondary Sources

Table 67: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Magnetoencephalography System Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	120.00 million
Revenue forecast in 2033	218.84 million
Growth rate	CAGR of 7.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Compumedics Neuroscan; RICOH; CTF MEG NEURO INNOVATIONS, INC.; MEGIN; Beijing Kunmai Medical Technology Co.,Ltd.; Beijing Weici Technology Co.,Ltd.; Magnetic Wave Intelligent Technology
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options